Company
Clover Biopharmaceuticals
We are a global commercial-stage biotechnology company committed to unleashing the power of innovative vaccines to save lives and improve health around the world.
Also known as Clover Biopharmaceuticals, Ltd.
- Status
- Operatingas of 2026-09-17Source (opens in a new tab)
- Business model
- B2B
- Founded
- 2007
- Legal name
- Clover Biopharmaceuticals, Ltd.
- cloverbiopharma.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Our mission is to harness transformative science and global partnerships to bring innovative vaccines to populations worldwide.
Funding snapshot
- Total raised
- $53.4MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $3.6M2026-03-27
Funding rounds
- Round, 2026
- $3.6M2026-03-27, SEC form D sold, 9 investors
- Round, 2024
- $905K2024-04-02, SEC form D sold, 13 investors
- Round, 2021
- $48.9M2021-04-18, SEC form D sold, 74 investors
Loading relationship preview